Hideki Iwamoto
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
Papers in
- Hepatology 60
- Hepatocellular Carcinoma Treatment and Prognosis 53
- Hepatitis C virus research 9
-
- Renal cell carcinoma treatment 15
- Prostate Cancer Diagnosis and Treatment 14
- Co-authors
- Takuji Torimura (69 shared papers)Hironori Koga (69 shared papers)Yihai Cao (12 shared papers)Atsushi Takenaka (64 shared papers)Shigeo Shimose (52 shared papers)Yunlong Yang (9 shared papers)Takashi Niizeki (51 shared papers)Sharon Lim (8 shared papers)
In The Last Decade
Hideki Iwamoto
164 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 110
- Hepatology 879
- Cancer Research 671
- Oncology 559
- Pulmonary and Respiratory Medicine 480
- Pathology and Forensic Medicine 233
Countries citing papers authored by Hideki Iwamoto
This map shows the geographic impact of Hideki Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Iwamoto more than expected).
Fields of papers citing papers by Hideki Iwamoto
This network shows the impact of papers produced by Hideki Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Iwamoto. The network helps show where Hideki Iwamoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Iwamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 247 | |
| 2 | 2014 | 151 | |
| 3 | 2015 | 133 | |
| 4 | 2013 | 116 | |
| 5 | 2013 | 100 | |
| 6 | 2016 | 90 | |
| 7 | 2016 | 90 | |
| 8 | 2021 | 83 | |
| 9 | 2018 | 66 | |
| 10 | 2018 | 65 | |
| 11 | 2020 | 61 | |
| 12 | 2019 | 56 | |
| 13 | 2020 | 54 | |
| 14 | 2016 | 52 | |
| 15 | 2023 | 51 | |
| 16 | 2012 | 49 | |
| 17 | 2015 | 48 | |
| 18 | 2014 | 48 | |
| 19 | 2020 | 48 | |
| 20 | 2020 | 46 |
About Hideki Iwamoto
Hideki Iwamoto is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Oncology, having authored 177 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (53 papers), Renal cell carcinoma treatment (15 papers), Cancer Mechanisms and Therapy (15 papers), Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Angiogenesis and VEGF in Cancer (11 papers), Hepatitis C virus research (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Hepatology (879 citations), Cancer Research (671 citations), Oncology (559 citations), Pulmonary and Respiratory Medicine (480 citations) and Pathology and Forensic Medicine (233 citations). Hideki Iwamoto has collaborated with scholars based in Japan, Sweden and China. Frequent co-authors include Takuji Torimura, Hironori Koga, Yihai Cao, Atsushi Takenaka, Shigeo Shimose, Yunlong Yang, Takashi Niizeki, Sharon Lim, Mitsuhiko Abe and Tomotake Shirono. Their work appears in journals such as Cancers, International Journal of Clinical Oncology, International Journal of Urology, Hepatology Research and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.